Literature DB >> 9414982

The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans.

C G Hillebrant1, B Nyberg, K Einarsson, M Eriksson.   

Abstract

BACKGROUND: The liver is a key organ in the metabolism of cholesterol in humans. It is the only organ by which substantial amounts of cholesterol are excreted from the body, either directly as free cholesterol into the bile or after conversion to bile acids. The major part of cholesterol synthesis in the body occurs in the liver. Cholesterol is also taken up by the liver from plasma lipoproteins. The relative contributions of newly synthesised cholesterol and plasma lipoprotein cholesterol to bile acid synthesis and biliary cholesterol secretion, respectively, are not known in detail. AIMS: To determine how a rapid lowering of plasma low density lipoprotein (LDL) and very low density lipoprotein (VLDL) cholesterol influences the biliary secretion rates of cholesterol and bile acids in patients with cholesterol gallstones and complete biliary drainage. In this model with a completely interrupted enterohepatic circulation, the secretion of bile acids equals the new synthesis of bile acids in the liver. PATIENTS: Eight patients with common bile duct stones of cholesterol type undergoing conventional cholecystectomy and choledocholithotomy.
METHODS: At operation a balloon occludable Foley catheter attached to a T tube was inserted into the bile duct with the balloon placed just past the distal limb of the T tube. The T tube was allowed to drain the bile externally. One week after the operation the Foley catheter balloon was inflated, creating complete biliary drainage. Twelve hours following the inflation plasma LDL apheresis was carried out for two hours. Bile was collected for 15 minute periods starting one hour before the apheresis and ending two hours after its termination. During the collection of bile, plasma lipids were analysed on several occasions.
RESULTS: The plasma level of LDL cholesterol decreased by 26% from (mean (SEM)) 2.19 (0.29) to 1.63 (0.17) mmol/l during the LDL apheresis while high density lipoprotein (HDL) cholesterol in plasma was unaffected. During LDL apheresis apolipoprotein B containing lipoproteins bind to the column, causing a significant decrease of not only plasma LDL but also of VLDL cholesterol. The secretion rate of bile acids decreased significantly by 31% from 131 (38) to 90 (16) mumol/15 minutes (p = 0.045). The output of phospholipids also decreased by 19%. The biliary secretion rate of cholesterol was not, however, affected by the plasma LDL apheresis.
CONCLUSIONS: The results suggest that, in patients with cholesterol gallstones and complete biliary drainage, lowering of plasma LDL and VLDL cholesterol reduces the biliary secretion rate--synthesis--of bile acids without affecting the biliary secretion rate of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414982      PMCID: PMC1891585          DOI: 10.1136/gut.41.5.700

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Enzymatic determination of cholesterol in bile.

Authors:  A Roda; D Festi; C Sama; G Mazzella; R Alini; E Roda; L Barbara
Journal:  Clin Chim Acta       Date:  1975-11-03       Impact factor: 3.786

2.  Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man.

Authors:  C C Schwartz; L G Halloran; Z R Vlahcevic; D H Gregory; L Swell
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

Review 3.  Disturbances of bile acid metabolism in intestinal disease.

Authors:  K W Heaton
Journal:  Clin Gastroenterol       Date:  1977-01

4.  Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3alpha-hydroxysteroid dehydrogenase.

Authors:  O Fausa; B A Skålhegg
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

5.  Identification of crystals deposited in brain and kidney after xylitol administration by biochemical, histochemical, and electron diffraction methods.

Authors:  G W Evans; G Phillips; T M Mukherjee; M R Snow; J R Lawrence; D W Thomas
Journal:  J Clin Pathol       Date:  1973-01       Impact factor: 3.411

6.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

Review 7.  A docking receptor for HDL cholesterol esters.

Authors:  D Steinberg
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

8.  Evidence for the existence of definitive hepatic cholesterol precursor compartments for bile acids and biliary cholesterol in man.

Authors:  C C Schwartz; Z R Vlahcevic; L G Halloran; D H Gregory; J B Meek; L Swell
Journal:  Gastroenterology       Date:  1975-12       Impact factor: 22.682

9.  Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites.

Authors:  C C Schwartz; M Berman; Z R Vlahcevic; L G Halloran; D H Gregory; L Swell
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

10.  Cholesterol determination in high-density lipoproteins separated by three different methods.

Authors:  M F Lopes-Virella; P Stone; S Ellis; J A Colwell
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

View more
  5 in total

Review 1.  Biliary cholesterol secretion: more than a simple ABC.

Authors:  Arne Dikkers; Uwe-Jf Tietge
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

2.  Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.

Authors:  F Lanzarotto; B Panarotto; R Sorbara; M Panteghini; F Pagani; S Sosta; A Lanzini
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

3.  Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women.

Authors:  Sergio Báez; Yasuo Tsuchiya; Alfonso Calvo; Martha Pruyas; Kazutoshi Nakamura; Chikako Kiyohara; Mari Oyama; Masaharu Yamamoto
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

4.  Hepatobiliary transport in health and disease.

Authors:  Jeannie Chan; John L Vandeberg
Journal:  Clin Lipidol       Date:  2012-04

5.  Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report.

Authors:  Alejandra Rosales; Maissa Mhibik; Paul Gissen; Oscar Segarra; Susana Redecillas; Gema Ariceta
Journal:  BMC Nephrol       Date:  2018-06-15       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.